Literature DB >> 25081945

Seroprevalence and risk factors of Mycoplasma suis infection in pig farms in central China.

Qiqi Song1, Weijing Zhang1, Weijiao Song1, Zehua Liu1, Muhammad Kasib Khan2, Lan He2, Rui Fang2, Peng Li3, Yanqin Zhou4, Min Hu1, Junlong Zhao5.   

Abstract

Mycoplasma suis, the causative agent of porcine infectious anemia, causes large economic losses to the swine industry worldwide. A questionnaire-based survey was conducted in 69 pig farms in Hubei Province, China, from November 2011 to August 2013 to ascertain the prevalence and associated risk factors of M. suis. Four thousand and four blood samples from pigs of all the age groups were tested for M. suis antibodies using the established rMSG1-ELISA assay. Among these 4004 samples, 1615 blood samples from multiparous sows were examined to identify the association between seroprevalence and different seasons. Information on risk factors collected from farmers or attending veterinarians was recorded on a pre-designed questionnaire. The overall test seroprevalence of M. suis infection at the animal level was 31.9% (1277/4004; 95% CI: 30.5%, 33.4%), whereas at the farm level, this value was 95.65% (66/69; 95% CI: 87.8%, 99.1%). The seroprevalence of M. suis was higher in replacement gilts (40.6%; 95% CI: 35.1%, 46.3%), multiparous sows (48.2%; 95% CI: 45.8%, 50.7%) and boars (44.4%; 95% CI: 34.5%, 54.8%), as compared to piglets (13.0%; 95% CI: 9.4%, 17.3%), weaned-piglets (10.8%; 95% CI: 8.9%, 13.0%), and growing-finishing pigs (25.0%; 95% CI: 22.0%, 28.3%). In terms of seasons, the prevalence of M. suis in pigs was significantly higher in summer (65.3%; 95% CI: 61.0%, 69.5%) and autumn (65.0%; 95% CI: 59.0%, 70.6%) compared to spring (30.1%; 95% CI: 26.0%, 34.4%) and winter (36.4%; 95% CI: 31.4%, 41.5%). Farm-level risk factors were identified by multivariable logistic regression analysis. The associated factors retained in the final multivariable logistic regression model were drug treatment, presence of mosquitoes and flies, and frequency of disinfection. Drug treatment (OR=0.24; 95% CI: 0.07, 0.88; P=0.031) and frequency of disinfection (OR=0.23; 95% CI: 0.06, 0.90; P=0.035) were protective factors, and the presence of mosquitoes and flies (OR=5.994; 95% CI: 1.56, 23.00; P=0.009) was a risk factor for M. suis infection on farms. The results of the present study provide the first insight into the impact of associated determinants on M. suis infection in central China.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Central China; Mycoplasma suis; Pigs; Risk factors; Seroprevalence

Mesh:

Year:  2014        PMID: 25081945     DOI: 10.1016/j.prevetmed.2014.07.006

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  4 in total

1.  Seroprevalence of Mycoplasma suis infection in pigs in eastern China as estimated by a blocking enzyme-linked immunosorbent assay.

Authors:  Liang Zhongyang; Zhang Jiansong; Shen Yijuan; Xia Yuting; Li Yufeng; Xu Jiarong
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

Review 2.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

3.  Mycoplasma suis Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals.

Authors:  Shujiang Xue; Kangseok Seo; Miaosen Yang; Chengdu Cui; Meng Yang; Siyu Xiang; Zongbin Yan; Shengjun Wu; Jincheng Han; Xiaoyang Yu; Yunxiao Li; Xin Jin
Journal:  Vaccines (Basel)       Date:  2021-12-20

Review 4.  Review of clinical aspects, epidemiology and diagnosis of haemotropic Mycoplasma ovis in small ruminants: current status and future perspectives in tropics focusing on Malaysia.

Authors:  Bura Thlama Paul; Faez Firdaus Abdullah Jesse; Eric Lim Teik Chung; Azlan Che-Amat; Mohd Azmi Mohd Lila; Hamza Abdirahman Hashi; Mohd Jefri Norsidin
Journal:  Trop Anim Health Prod       Date:  2020-07-26       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.